Modern radiopharmaceuticals for lung cancer imaging with positron emission tomography/computed tomography scan: A systematic review
Introduction: In this study, we evaluated the use and the contribution of radiopharmaceuticals to the field of lung neoplasms imaging using positron emission tomography/computed tomography. Methods: We conducted review of the current literature at PubMed/MEDLINE until February 2020. The search langu...
Main Authors: | Athanasios S Theodoropoulos, Ioannis Gkiozos, Georgios Kontopyrgias, Adrianni Charpidou, Elias Kotteas, George Kyrgias, Maria Tolia |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-09-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312120961594 |
Similar Items
-
Radiopharmaceuticals for positron emission tomography /
by: Scott, Peter J. H., et al.
Published: (c201) -
Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer
by: Chaninart Sakulpisuti, et al.
Published: (2022-08-01) -
Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
by: Christos Sachpekidis, et al.
Published: (2019-12-01) -
Positron emission tomography: Evolving modalities, radiopharmaceuticals and professional collaboration
by: Sally L. Ayesa, et al.
Published: (2022-12-01) -
Positron emission tomography in breast cancer: 18F- FDG and other radiopharmaceuticals
by: Ioannis Iakovou, et al.
Published: (2018-10-01)